Evidence map›Paper›PMID 33377637›Full record

ArticleClinical and translational medicine2020

Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer.

Frauke Goeman, Francesca De Nicola, Carla Azzurra Amoreo, Stefano Scalera, Daniele Marinelli, Francesca Sperati, Marco Mazzotta, Irene Terrenato, Matteo Pallocca, Ludovica Ciuffreda and 19 more

Abstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Frauke GoemanOncogenomic and Epigenetic Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Francesca De NicolaSAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Carla Azzurra AmoreoDepartment of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Stefano ScaleraSAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Daniele MarinelliMedical Oncology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, "Sapienza" University of Rome, Rome, Italy.
Francesca SperatiBiostatistics Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Marco MazzottaDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Irene TerrenatoBiostatistics-Scientific Direction, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Matteo PalloccaSAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Ludovica CiuffredaSAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Eleonora SperandioSAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Maddalena BarbaDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Laura PizzutiDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Domenico SergiDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Antonella AmodioDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Giancarlo PaolettiDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Eriseld KrasniqiDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Patrizia ViciDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Beatrice CasiniDepartment of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Enzo GalloDepartment of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Simonetta BuglioniDepartment of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Maria Grazia DiodoroDepartment of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Edoardo PescarmonaDepartment of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Ilio VitaleItalian Institute for Genomic Medicine (IIGM), IRCSS Candiolo, Turin, Italy.
Ruggero De MariaInstitute of General Pathology, Catholic University of the Sacred Heart, Rome, Italy.
Gian Luca GraziHepato-Pancreato-Biliary Surgery, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Gennaro CilibertoScientific Direction, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Maurizio FanciulliSAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Marcello Maugeri-SaccàDivision of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.ORCID https://orcid.org/0000-0003-2287-9581

Funding

Associazione Italiana per la Ricerca sul CancroGastrointestinal Tumors Translational Research GroupMy First AIRC GrantYoung Investigator Grant
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33377637
PMCPMC7770515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.